|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2006-1-24
|
|
pubmed:abstractText |
The safety and efficacy of paricalcitol injection have been well established for the prevention and treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD) stage 5. The capsule form of paricalcitol was developed to provide a convenient dosage form for patients with stages 3 and 4 CKD.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1523-6838
|
|
pubmed:author |
pubmed-author:AbboudHannaH,
pubmed-author:AcharyaMuralidharM,
pubmed-author:AndressDennis LDL,
pubmed-author:BatlleDanielD,
pubmed-author:CoyneDanielD,
pubmed-author:FademStephenS,
pubmed-author:LevineBartonB,
pubmed-author:QiuPingP,
pubmed-author:RosanskyStevenS,
pubmed-author:SpragueStuart MSM,
pubmed-author:WilliamsLauraL
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
263-76
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16431255-Adult,
pubmed-meshheading:16431255-Aged,
pubmed-meshheading:16431255-Aged, 80 and over,
pubmed-meshheading:16431255-Capsules,
pubmed-meshheading:16431255-Disease Progression,
pubmed-meshheading:16431255-Double-Blind Method,
pubmed-meshheading:16431255-Ergocalciferols,
pubmed-meshheading:16431255-Female,
pubmed-meshheading:16431255-Humans,
pubmed-meshheading:16431255-Hyperparathyroidism, Secondary,
pubmed-meshheading:16431255-Kidney Failure, Chronic,
pubmed-meshheading:16431255-Male,
pubmed-meshheading:16431255-Middle Aged,
pubmed-meshheading:16431255-Prospective Studies
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD.
|
|
pubmed:affiliation |
Renal Division, Department of Internal Medicine, Chromalloy American Kidney Center, Washington University, St Louis, MO, USA.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
